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Abstract
 
The differentiation of CD4
 
1
 
 T cells into T helper type 1 (Th1) cells is driven by interleukin
 
(IL)-12 through the IL-12 receptor 
 
b
 
2 (IL-12R
 
b
 
2) chain, whereas differentiation into Th2
cells is driven by IL-4, which downregulates IL-12R
 
b
 
2 chain. We reexamined such differenti-
ation using IL-12R
 
b
 
2 chain transgenic mice. We found that CD4
 
1
 
 T cells from such mice
were able to differentiate into Th2 cells when primed with IL-4 or IL-4 plus IL-12. In the lat-
ter case, the presence of IL-4 suppressed interferon (IFN)-
 
g
 
 production 10–100-fold compared
with cells cultured in IL-12 alone. Finally, in studies of the ability of IL-12 to convert Th2 cells
bearing a competent IL-12R to the Th1 cells, we showed that: (a) T cells bearing the IL-
12R
 
b
 
2 chain transgene and primed under Th2 conditions could not be converted to Th1 cells
by repeated restimulation under Th1 conditions; and (b) established Th2 clones transfected
with the IL-12R
 
b
 
2 chain construct continued to produce IL-4 when cultured with IL-12.
These studies show that IL-4–driven Th2 differentiation can occur in the presence of persistent
IL-12 signaling and that IL-4 inhibits IFN-
 
g
 
 production under these circumstances. They also
show that established Th2 cells cannot be converted to Th1 cells via IL-12 signaling.
Key words: cytokine • interleukin 4 • reversibility • signal transducer and activator of 
transcription 4 • T helper type 1
 
Introduction
 
An important goal of recent immunological study is the
elucidation of the molecular events governing the differen-
tiation of naive CD4
 
1
 
 T cells into Th1 and Th2 cells. For
the most part, such study has focused on the effects of vari-
ous cytokines on developing T cells (1). As a result, it is
now clear that IL-4 induces naive CD4
 
1
 
 T cells to differ-
entiate into Th2 cells (2–6), in large measure through its
ability to activate signal transducer and activator of tran-
 
scription (STAT)
 
1
 
 6 (7–9), a transcription factor that binds
to the IL-4 gene (10). Other transcription factors such as
c-Maf and GATA-3 are also induced during Th2 cell dif-
ferentiation (11, 12), but it is not yet known how these fac-
tors interact with STAT6, if they do so at all. It is also now
clear that IL-12 induces naive CD4
 
1
 
 T cells to differentiate
into Th1 cells (13–15) and that such differentiation is af-
fected by the activation of STAT4 (16–19), a transcription
factor that binds to the IFN-
 
g
 
 gene (20).
Although in separate cultures of naive T cells, IL-4 in-
duces Th2 cells and IL-12 induces Th1 cells, when both
cytokines are present in the same culture the IL-4 effect is
predominant and Th2 cells develop in the presence of IL-
12 (13, 14). These observations have been explained by the
effect of the various cytokines on IL-12R expression, or,
more specifically, the expression of the IL-12R
 
b
 
2 chain,
the receptor component that is rapidly upregulated by
TCR stimulation and is required for STAT4 activation
(21–25). In particular, it has been postulated that IL-4
downregulates the expression of the IL-12R
 
b
 
2 chain and
in so doing prevents IL-12 from transducing its signal; this
then allows unopposed IL-4–directed differentiation (1).
Conversely, IFN-
 
g
 
 (in mice) maintains IL-12R
 
b
 
2 chain
expression even in the presence of IL-4 and hence sustains
IL-12 responsiveness (1, 23, 26). In this view, the regula-
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tion of the IL-12R
 
b
 
2 chain is a critical regulator of Th1/
Th2 differentiation.
However, it should be noted that the data so far obtained
do not exclude the alternative possibility that although op-
timal Th1 cell differentiation requires IL-12R
 
b
 
2 chain ex-
pression and STAT4 activation, Th2 cell development can
occur in spite of such expression and activation. To exam-
ine this possibility, we studied Th1/Th2 cell differentiation
in CD4
 
1
 
 T cells obtained from IL-12R
 
b
 
2 chain transgenic
mice that constitutively express the IL-12R
 
b
 
2 chain as well
as in Th2 cell clones transfected with an IL-12R
 
b
 
2 chain
construct. The results showed that CD4
 
1
 
 T cells stimulated
via the TCR can be induced to become Th2 cells by IL-4
despite continuing expression of IL-12R
 
b
 
2 chain and IL-
12–induced STAT4 activation. Thus, while expression of
the IL-12R
 
b
 
2 chain may be a critical regulator of Th1 dif-
ferentiation, it cannot turn off an IL-4–initiated Th2 differ-
entiation program.
 
Materials and Methods
 
Reagents.
 
Culture medium used for D10.G4.1 (D10) cells
was Click’s medium (Biosource International) with 10% FCS,
100 
 
m
 
g/ml streptomycin, 100 U/ml penicillin, 50 
 
m
 
M 2-ME, 10
U/ml human IL-2 (Life Technologies), and 6% rat Con A super-
natants (27). Culture medium used for primary cell lines was
RPMI 1640 (BioWhittaker) with 10% FCS, 100 
 
m
 
g/ml strepto-
mycin, 100 U/ml penicillin, 15 mM Hepes, pH 7.0, 5% NCTC-
109 (Biosource International). Murine IL-4, human IL-2, and
murine IL-12 were purchased from PeproTech, Life Technolo-
gies, and R&D Systems, respectively. Anti–mouse IL-4 mAb
(clone 11B11) was purchased from National Cancer Institute. Bi-
otinylated mouse anti–mouse IL-12R
 
b
 
1 chain mAb was pro-
vided by Dr. C.Y. Wu (National Institute of Allergy and Infec-
tious Diseases). Hamster anti–mouse IL-12R
 
b
 
2 chain mAb
(PDL-HAM10B9) was made by immunizing hamster with Chi-
nese hamster ovary (CHO) cells transfected with mouse IL-
12R
 
b
 
2 chain cDNA. The specificity of PDL-HAM10B9 was
confirmed by flow cytometry analysis of CHO cells transfected
with mouse IL-12R
 
b
 
2 chain cDNA, Con A–stimulated spleno-
cytes of wild-type and IL-12R
 
b
 
2 chain knockout mice (Hoff-
man-La Roche). OVA peptide (323–339) was purchased from
American Peptide Company, Inc.
 
Cell Culture.
 
D10 cells were purchased from American Type
Culture Collection (27), and were stimulated every 2–3 wk with
0.5 
 
3
 
 10
 
6
 
/ml 35 Gy–irradiated AKR splenocytes and 100 
 
m
 
g/ml
conalbumin (Sigma-Aldrich). Splenocytes from OVA-TCR and
IL-12R
 
b
 
2 chain double transgenic mice or OVA-TCR single
transgenic mice were isolated, and CD4
 
1
 
 cells were purified by
mouse CD4 columns that are based on negative selection for
CD4
 
1
 
 cells (R&D Systems). CD4
 
1
 
CD62L
 
high
 
 cells were further
purified by FACS
 
®
 
 sorting with CD4-FITC and CD62L-PE by
the National Institute of Allergy and Infectious Diseases Flow
Cytometry Unit. The isolated cells (
 
.
 
98% CD4
 
1
 
CD62L
 
high
 
)
were stimulated with 1.5 
 
3
 
 10
 
6
 
/ml 30 Gy–irradiated T cell–
depleted Balb/c splenocytes and 0.3 
 
m
 
M OVA peptide. The ad-
ditional cytokines and anticytokine mAb are IL-4 (200 U/ml),
IL-12 (2 ng/ml), and anti–IL-4 mAb 11B11 (10 
 
m
 
g/ml). T cell
lines were expanded with 20 U/ml human IL-2 and additives 72 h
after stimulation. T cell lines were stimulated weekly with OVA
peptide and APCs as described above except that irradiated whole
splenocytes were used as APCs at the concentration of 2.5 
 
3
 
 10
 
6
 
/ml. T cell–depleted Balb/c splenocytes were made by comple-
ment lysis with guinea pig complement (Life Technologies), anti-
CD8
 
a
 
 mAb (clone 2.43), anti-CD4 mAb (clone GK1.5), anti-
Thy1.2 mAb (clone 30-H12), and anti–rat IgG mAb (clone
MAR18.5). After T cell depletion treatment, CD3
 
e
 
1
 
 cells were
 
,
 
3% by flow cytometry analysis.
 
Plasmid Construction.
 
VAhCD2 minigene vector (28) and
mouse IL-12R
 
b
 
2 chain cDNA (21) were provided by Dr. D.
Kioussis (National Institute for Medical Research, London, UK)
and Dr. U. Gubler (Hoffman-La Roche Inc., Nutley, NJ), re-
spectively. FLAG epitope tag sequence (5
 
9
 
-GATTACAAG-
GACGACGATGACAAG-3
 
9
 
) was inserted before the stop
codon of mouse IL-12R
 
b
 
2 chain cDNA by PCR, and con-
firmed by sequencing with an ABI PRISM 377 sequencer. The
FLAG-tagged mouse IL-12R
 
b
 
2 cDNA was inserted into the
VAhCD2 minigene vector using conventional subcloning tech-
nique (VAhCD2IL-12R
 
b
 
2FLAG). For making transgenic mice,
we inserted 2.8-kb NheI–AflII fragment of mouse IL-12R
 
b
 
2
cDNA into the VAhCD2 minigene vector after performing
EcoRI linker ligation (VAhCD2IL-12R
 
b
 
2). We then isolated a
14.2-kb fragment after digesting SalI–NotI for microinjection
into C57BL/6 OVA. The total cDNA sequence of the final
clone was confirmed by sequencing.
 
Mice.
 
Balb/c and AKR mice were purchased from National
Cancer Institute. The Balb/c background OVA-TCR transgenic
mouse DO11.10, which recognizes the 323–339 peptide of OVA
in the context of I-A
 
d
 
, was provided by Dr. D. Loh (Washington
University School of Medicine, St. Louis, MO [29]). IL-12R
 
b
 
2
chain transgenic mice were created by microinjection of
VAhCD2IL-12R
 
b
 
2 construct into C57BL/6 OVA in the Na-
tional Institute of Allergy and Infectious Diseases Transgenic Fa-
cility, resulting in two founders: 1818 (about six copies) and 1826
(less than one copy). From the founder 1818, the transgenes were
segregated, and we used three lines with about two to three cop-
ies for backcrossing to Balb/c. Transgenic mice were maintained
in heterozygous condition for the IL-12R
 
b
 
2 chain transgene. Af-
ter backcrossing two to three times to Balb/c and checking
MHC class II type of peripheral blood by flow cytometry, IL-
12R
 
b
 
2 chain transgenic mice (heterozygous for the transgene)
homozygous for I-A
 
d
 
 were mated with Balb/c background
OVA-TCR transgenic mice DO11.10 (homozygous for the
OVA-TCR transgene). Screening for IL-12R
 
b
 
2 chain transgene
was performed by PCR with tail DNA using primers 5
 
9
 
-GCAT-
ACGTTCACGTTCTTGG-3
 
9
 
 and 5
 
9
 
-CAGAAGCGCCTTT-
TGAGTTG-3
 
9
 
. In each experiment, spleens from two to three
mice, 4–12 wk old, were pooled for isolation of CD4
 
1
 
 cells and
littermates were used as control.
 
Transfection.
 
10
 
7
 
 D10 cells in 0.4 ml were transfected by elec-
troporation with 20 
 
m
 
g VAhCD2IL-12R
 
b
 
2FLAG and 1 
 
m
 
g
pSV2Neo (a gift of Dr. J. Cohen, National Institute of Allergy
and Infectious Diseases). The electroporation was performed with
a BTX electroporator at 280 V, 1,050 
 
m
 
F, and R10 in 0.4-cm-
gap cuvette. Immediately after electroporation, cells were trans-
ferred to culture medium, incubated overnight, and stimulated
with irradiated AKR mice splenocytes and conalbumin. 48 h af-
ter stimulation, the transfected cells were plated in 96-well plates
with 500 
 
m
 
g/ml G418 (Life Technologies). Positive clones were
screened by FACS
 
®
 
 analysis with anti–mouse IL-12R
 
b
 
2 chain
mAb and Western blotting for FLAG epitope. The transfectants
were maintained in culture medium with 200 
 
m
 
g/ml G418.
 
ELISA.
 
To measure cytokines, 5 
 
3
 
 10
 
5
 
/ml T cells were
stimulated with coated anti–mouse CD3
 
e
 
 (5 
 
m
 
g/ml; PharMin- 
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gen) plus soluble anti–mouse CD28 (1 
 
m
 
g/ml; PharMingen),
mouse IL-12 (5 ng/ml) plus mouse IL-18 (100 ng/ml; R&D Sys-
tems), and irradiated APCs plus antigen (IL-12 plus IL-18 stim-
ulation was used to get maximal IFN-
 
g
 
 production through
IL-12R instead of IL-12 stimulation). IL-4 and IFN-
 
g
 
 concen-
trations in the supernatants were measured by Endogen ELISA
minikits after the supernatants were diluted to be measured in lin-
ear range. The samples are measured in duplicate, and averages
were shown.
 
Flow Cytometry.
 
Flow cytometry was performed using stan-
dard procedures using rat anti–mouse CD4-FITC (PharMingen),
rat anti–mouse CD62L-PE (PharMingen), biotinylated mouse
anti–mouse IL-12R
 
b
 
1 chain mAb, hamster anti–mouse IL-
12R
 
b
 
2 chain mAb (PDL-HAM10B9), hamster anti-TNP mAb
(PharMingen), biotinylated goat anti–hamster IgG (H
 
1
 
L) (Jack-
son ImmunoResearch Laboratories), and streptavidin-PE (Phar-
Mingen). For staining for mouse IL-12R
 
b
 
2 chain, cells were
stained sequentially with PDL-HAM10B9, with biotinylated goat
anti–hamster IgG (H
 
1
 
L; Jackson ImmunoResearch Laboratories
Inc.), and with streptavidin-PE (PharMingen) and rat anti–mouse
CD4-FITC (PharMingen). The analysis was performed on a Bec-
ton Dickinson FACScan™ flow cytometer with CELLQuest™
II software.
 
Proliferation Assay.
 
T cells were plated at the concentration of
0.5 3 106/ml for primary cell lines and 0.2 3 106/ml for D10
cell transfectants, and cultured with varying concentrations of IL-
12. The cultures were incubated for 24 h and pulsed with 1 mCi
of [3H]thymidine for the last 6 h.
Intracellular Cytokine Staining. T cells subjected to intracellu-
lar cytokine staining were cells from T cell lines from double and
single transgenic mice as described above. 7 d after antigen stimu-
lation, 98–99% of these cells expressed CD4 and OVA-TCR
clonotype recognizing mAb KJ1-26 as determined by flow cy-
tometry (data not shown). T cell lines were washed extensively
and stimulated with 20 ng/ml PMA (Sigma-Aldrich), 1 mM ion-
omycin (Calbiochem Corp.), and 2 mM monensin (Calbiochem
Corp.) for 6 h. The stimulated cells were treated with 20 mg/ml
DNaseI (Roche Molecular Biochemicals) for 5 min, washed, in-
cubated with FcBlock (PharMingen), and fixed with 4% formal-
dehyde (Polysciences Inc.) in PBS. The fixed cells were treated
with PBS containing 5% nonfat dry milk, 0.1% saponin, 1 mM
CaCl2, 1 mM MgSO4, 0.05% NaN3, 1% BSA, 10 mM Hepes, pH
7.0 for 30 min, incubated for 30 min with 2 mg/ml anti–mouse
IFN-g–FITC (XMG1.2; PharMingen) and 2 mg/ml anti–mouse
IL-4–PE (BVD4-1D11; PharMingen), and then washed with the
same buffer without nonfat dry milk (30). As negative controls,
directly labeled isotype-matched mAbs were used. Flow cyto-
metric analysis was performed as described above.
Immunoprecipitation and Western Blotting. Cells were washed
extensively, resuspended at 4 3 106/ml with 0.5% FCS Click’s
medium, and incubated for 1 h. 20 min after addition of mouse
IL-12 (5 ng/ml), the cells were washed two times with cold PBS
and lysed with 200 ml of lysis buffer (10 mM Tris-HCl, pH 7.5,
150 mM NaCl, 1% NP-40, 0.25% sodium deoxycholate, 1 mM
EDTA, 1 mM EGTA, 10 mM NaF, 1 mM Na3VO4, and protein
inhibitor cocktail; Roche Molecular Biochemical). After 30 min
incubation at 48C, the lysates were microcentrifuged for 30 min.
The supernatants were collected, and mixed with 1 mg of normal
rabbit IgG and 20 ml of protein A–agarose for 15 min. After cen-
trifugation, the supernatants were incubated with 1 mg of anti-
STAT4 (Santa Cruz Biotechnology) or anti-STAT3 antibody
(Santa Cruz Biotechnology) for 1 h, added with protein A–aga-
rose, and incubated overnight. The protein A–agarose was washed
four times with lysis buffer without proteinase inhibitor, then
eluted with SDS sample buffer at 958C for 5 min. The samples
were run in SDS-PAGE in reducing conditions, and transferred
to Protran nitrocellulose membrane (Schleicher & Schuell). The
blotted membranes were blocked with 2% BSA TBS-T, probed
with 0.2 mg/ml horseradish peroxidase–labeled antiphosphoty-
rosine mAb (4G10; Upstate Biotechnology Inc.), and developed
by Supersignal Chemiluminescence kit (Pierce Chemical Co.).
After stripping, the membranes were reprobed with anti-STAT
antibodies.
For the detection of the FLAG epitope tag of D10 cells trans-
fected with VAhCD2IL-12Rb2FLAG, 106 cells were lysed in 20
ml of lysis buffer (0.5% Triton X-100, 300 mM NaCl, 50 mM
Tris-HCl, pH 7.5, proteinase inhibitor cocktail (Roche Molecu-
lar Biochemical), incubated for 45 min, centrifuged for 15 min,
and 0.2% SDS/0.2% sodium deoxycholate (final concentration)
was added to collected supernatants. The lysates were mixed with
the SDS sample buffer, boiled for 5 min, gel electrophoresed in
reducing conditions, and transferred to the nitrocellulose as de-
scribed above. The blot was blocked with 5% nonfat dry milk
TBS-T, probed with rabbit anti-FLAG antibody (Santa Cruz
Biotechnology), and developed as described above.
Northern Blotting. Total RNA was isolated with RNA
STAT-60 RNA isolation kit (Tel-Test, Inc.). Mouse c-Maf
cDNA (550 bp), which was PCR amplified with primers 59-
GAGCAGTTGGTGACCATGTC-39  and 59-CACCACAA-
GCTTGGTGTGTG-39 and verified by sequencing, ClaI–NcoI
fragment (1.1 kb) of mouse GATA-3 cDNA (provided by Dr. J.
Engel, Northwestern University, Evanston, IL), and mouse glyc-
eraldehyde 3-phosphate dehydrogenase (GAPDH) cDNA (905
bp; Ambion Inc.) were used for probe synthesis. The probes were
made with random primer kits (Amersham Pharmacia Biotech)
with [a-32P]dCTP (3,000 Ci/mmol; Amersham Pharmacia Bio-
tech). 10 mg of total RNA for D10 cells and 6 mg for primary T
cell lines were separated on formaldehyde gel, and transferred
to Nytran nylon membrane (Schleicher & Schuell) by capillary
blotting. The blotted membranes were prehybridized and hybrid-
ized according to the manufacturer’s protocol. After washing, the
blot was exposed to a PhosphorImager® plate (Molecular Dy-
namics).
Results
Effect of Persistent IL-12R Expression on Naive T Cell Dif-
ferentiation into Th2 Cells. In initial studies, we determined
the capacity of naive CD41 T cells that constitutively ex-
press the IL-12Rb2 chain to undergo Th2 cell differentia-
tion (here defined by the ability of the CD41 T cells to
produce IL-4). For this purpose, we constructed IL-12Rb2
chain transgenic mice expressing the IL-12Rb2 chain on T
cells under the control of the human CD2 promoter/en-
hancer (the VAhCD2 minigene vector) (21, 28). As shown
in Fig. 1 A, spleen CD41 T cells from such transgenic mice
do in fact manifest constitutive expression of the IL-12Rb2
chain, as determined by flow cytometric analysis of cells
stained with an IL-12Rb2 chain–specific mAb (PDL-
HAM10B9). To obtain CD41 T cells expressing the IL-
12Rb2 chain transgene that respond to a particular antigen
(OVA peptide), we made double transgenic mice by cross-
ing the IL-12Rb2 chain transgenic mice (backcrossed for
two to three generations with Balb/c mice) to DO11.10850 Th2 Cell Differentiation in the Presence of IL-12Rb2 Chain Expression
Balb/c mice expressing the TCR specific for OVA peptide
in the context of I-Ad (29).
With the above double transgenic mice (as well as single
transgenic littermates bearing the OVA-TCR transgene in
the absence of the IL-12Rb2 chain transgene) in hand, we
stimulated flow-sorted naive CD41 splenocytes from the
transgenic mice with OVA peptide presented by irradiated
syngeneic Balb/c T cell–depleted APCs in the presence of
IL-4 (200 U/ml). As shown in Table I, after culture for 1
wk under these conditions, cells obtained from both the
double transgenic and single transgenic mice produce large
amounts of IL-4 and only small amounts of IFN-g and had
thus differentiated into Th2 cells. Nevertheless, as shown in
Fig. 1 B, CD41 T cells from the double transgenic mice
(double transgenic T cells) continued to express the IL-
12Rb2 chain on days 3, 5, and 7 after OVA stimulation in
the presence of IL-4, whereas control CD41 T cells from
single transgenic mice (single transgenic T cells) expressed
little or no IL-12Rb2 chain. In additional studies, we
showed that the CD41 T cells that develop into Th2 cells
Figure 1. (A) IL-12Rb2 chain expression on CD41 cells from double transgenic mice (bearing an IL-12Rb2 chain transgene and an OVA-TCR
transgene) and single transgenic mice (bearing an OVA-TCR transgene only). Histograms of gated CD41 cells are shown. (B) IL-12Rb2 chain expres-
sion on T cell lines primed in vitro. CD41CD62Lhigh splenocytes from double transgenic mice bearing an IL-12Rb2 chain transgene and an OVA-TCR
transgene (double Tg) and single transgenic mice bearing an OVA-TCR transgene only (single Tg) were stimulated with antigen (OVA peptide) and
APCs without any cytokine addition, with IL-4 (200 U/ml), with IL-12 (2 ng/ml), or with IL-4 (200 U/ml) plus IL-12 (2 ng/ml), and stained for IL-
12Rb2 chain on CD41 cells on day 3, 5, and 7 after priming. Each group of cells was stained with anti–mouse IL-12Rb2 chain mAb (solid line) and
control mAb (dashed line). Histograms of gated CD41 cells are shown.851 Nishikomori et al.
from double transgenic mice express a functional IL-12R.
Thus, as shown in Fig. 2, A and B, these cells proliferate in
response to exogenous IL-12 added on day 7 after initiation
of culture and display STAT4 tyrosine phosphorylation,
whereas cells from the single transgenic mice exhibit little
or no such function. Overall, these studies provide initial
evidence that early Th2 cell differentiation and IL-4 pro-
duction can occur in the presence of persistent expression
of a competent IL-12R. In addition, they confirm that un-
like IFN-g, IL-12 does not suppress Th2 cell proliferation
(31–33).
One potential objection to the above results arises from
the possibility that Balb/c APCs are poor IL-12 producers
and thus that there was not enough endogenous IL-12 gen-
erated in the cultures to prevent Th2 cell development
even though competent IL-12R was being expressed; we
therefore determined Th2 cell differentiation in double
transgenic T cells in the presence of exogenous IL-12 (13,
14). In this experiment, we added IL-12 (2 ng/ml; i.e.,
enough IL-12 to induce a robust Th1 cell response in the
absence of IL-4) to cultures of naive CD41 T cells from
double and single transgenic mice primed with antigen in
the presence of IL-4 (200 U/ml). As also shown in Fig. 2,
A and B, CD41 T cells from double transgenic mice con-
tinued to express functional IL-12Rb2 chain, as evidenced
by their ability to manifest STAT4 tyrosine phosphoryla-
tion and T cell proliferation in the presence of IL-12. In
contrast, under the same conditions CD41 T cells from sin-
gle transgenic mice expressed greatly reduced amounts of
functional IL-12Rb2 chain. Furthermore, as shown in Ta-
ble II, IL-4 production in cultures of double transgenic T
cells in the presence of exogenous IL-12 was similar to (al-
beit slightly lower than) IL-4 production by such T cells in
the absence of IL-12. Finally, although addition of IL-12
did induce low-level IFN-g production in double trans-
genic T cells cultured with IL-4 plus IL-12, such produc-
tion was z10–100-fold lower than that exhibited by such
T cells stimulated by antigen in the presence of IL-12
alone.
In further studies, we analyzed Th2 cell differentiation in
cultures of double and single transgenic T cells at the single
cell level by performing flow cytometry on cultured cells
stained for detection of intracellular IL-4 and IFN-g. As
shown in Fig. 3, double transgenic T cells cultured with
IL-4 alone gave rise to at least as many and perhaps more
Table I. Cytokine Production in Cultures of CD41 T Cells from 
IL-12Rb2 Chain and OVA-TCR Double Transgenic Mice 7 d after 
Antigen Stimulation
IFN-g IL-4
Antigen
CD3
1CD28
IL-12
1IL-18 Antigen
CD3
1CD28
Single Tg 1 IL-4 0 2 3 36 349
Double Tg 1 IL-4 2 8 2 40 352
Single Tg 1 IL-12 2,480 2,499 388 6 0
Double Tg 1 IL-12 2,713 3754 689 1 0
Sorted CD41CD62Lhigh splenocytes from IL-12Rb2 chain and OVA-
TCR double transgenic (double Tg) and OVA-TCR transgenic
littermates (single Tg) were primed with OVA peptide, irradiated T
cell–depleted Balb/c splenocytes (APCs), and additional cytokines (200
U/ml IL-4, 2 ng/ml IL-12). 7 d after priming, CD41 T cell lines were
restimulated as above, and 48 h later supernatants were collected for
cytokine measurements. Results (in ng/ml) show data from one of five
independent experiments.
Figure 2. (A) Proliferation of primary T cell lines in response to IL-12. T cell lines from single and double transgenic mice primed with IL-4 (200 U/ml)
or with IL-4 (200 U/ml) plus IL-12 (2 ng/ml) were harvested 7 d after priming, washed extensively, and recultured with varying concentrations of IL-12
(0–1.0 ng/ml) for 24 h; cultures were pulsed with 1 mCi of [3H]thymidine during the last 6 h. Error bars indicate SEM of triplicate cultures. Values ob-
tained with varying IL-12 concentrations are compared with values obtained without IL-12 by Student’s t test (*P , 0.05). (B) Immunoprecipitation
Western blots for detection of tyrosine phosphorylation of STAT4 in primary T cell lines. Single transgenic T cells and double transgenic T cells were
primed with IL-4, with IL-4 and IL-12, or with IL-12, harvested 7 d after priming, washed extensively, and stimulated with (1) or without (2) IL-12
(5 ng/ml) for 20 min. The same blot was stripped and reprobed with anti-STAT4 antibody.852 Th2 Cell Differentiation in the Presence of IL-12Rb2 Chain Expression
IL-41/IFN-g2 cells (45.5%) as single transgenic T cells
(27.4%). Perhaps more importantly, while double trans-
genic T cells cultured with IL-4 and IL-12 (2 ng/ml) gave
rise to a greater number of IFN-g1 (IL-41 or IL-42) T
cells (12.3%) than did single transgenic T cells (2.2%), both
cell populations gave rise to the same number of IL-41/
IFN-g2 cells (z36%). Finally, we determined IL-12Rb2
chain expression in double transgenic cells stimulated with
IL-4 and IL-12 using triple staining for IFN-g, IL-4, and
IL-12Rb2 chain and confirmed that cells in each quadrant
of the relevant panels of Fig. 3 expressed similar level of IL-
12Rb2 chain (data not shown). This provides direct proof
that both IL-41/IFN-g2 and IL-41/IFN-g1 cells cultured
in the presence of IL-12 retain IL-12Rb2 chain expression.
In a final series of studies along these lines, we also deter-
mined if high doses of IL-12 added to cultures of double
transgenic T cells could reverse IL-4–induced Th2 differ-
entiation (Table II, and Fig. 3). In these studies, the effect
on T cell differentiation was again measured by cytokine
secretion in culture supernatant measured by ELISA and by
intracellular cytokine expression measured by flow cytom-
etry. As shown in Table II, although addition of high doses
of IL-12 (25 ng/ml) to cultures of double transgenic T cells
containing IL-4 led to a decrease in IL-4 production, the
latter was still the dominant cytokine being secreted. In ad-
dition, as shown in Fig. 3, while double transgenic T cells
cultured with IL-4 and high doses of IL-12 (25 ng/ml)
gave rise to about half the number of cells producing IL-4
alone (17.8%) as cells cultured with low doses of IL-12 (2
ng/ml), this population still remained the main population
in this condition.
Taken together, these studies show that the presence of a
competent IL-12R containing the IL-12Rb2 chain does
not prevent Th2 cell differentiation induced by IL-4 even
when IL-12 is present and stimulates the T cell via its re-
ceptor.
Effect of Persistent IL-12R Expression on Established Th2
Cells. Having established that neither expression of the
IL-12Rb2 chain nor signaling through the IL-12R can
shut down naive CD41 T cell differentiation into IL-4–
producing cells driven by IL-4, we turned our attention to
whether such expression and signaling could induce the
conversion of Th2 cells into Th1 cells. In initial studies
along these lines, we transfected an established mouse Th2
Table II. Cytokine Production of CD41 T Cell Lines Primed 
with IL-4 plus IL-12
IFN-g IL-4
Antigen
CD3
1CD28
IL-12
1IL-18 Antigen
CD3
1CD28
Single Tg 1 IL-4 0 1 0 55 272
Double Tg 1 IL-4 0 35 8 73 640
Single Tg 1 IL-4
1 IL-12 (2)* 0 0 0 78 777
Double Tg 1 IL-4
1 IL-12 (2)* 17 294 171 60 328
Single Tg 1 IL-4
1 IL-12 (25)* 0 63 0 60 378
Double Tg 1 IL-4
1 IL-12 (25)* 49 451 311 42 217
Single Tg 1 IL-12 5,612 1,556 1,303 0 0
Double Tg 1 IL-12 7,240 4,490 1,438 0 0
Sorted CD41CD62Lhigh splenocytes from IL-12Rb2 chain and OVA-
TCR double transgenic (double Tg) and OVA-TCR transgenic
littermates (single Tg) were primed with OVA peptide, APCs, IL-4 (200
U/ml), IL-12 (2 ng/ml), or IL-4 (200 U/ml) plus IL-12 at the indicated
concentrations (2 or 25 ng/ml). Results (in ng/ml) shown represent data
from one of three independent experiments.
*IL-12 concentration (in ng/ml).
Figure 3. Intracellular cytokine staining for IL-4 and IFN-g in T cell
lines obtained from single and double transgenic mice. T cell lines were
harvested 7 d after priming with IL-4 (200 U/ml), with IL-12 (2 ng/ml),
with IL-4 (200 U/ml) plus IL-12 (2 ng/ml), or with IL-4 (200 U/ml)
plus IL-12 (25 ng/ml), washed extensively, and stimulated with PMA and
ionomycin as described in Materials and Methods. Cell populations were
assigned quadrants based on isotype-matched labeled control mAbs. The
percentage of cells in each quadrant is also shown. Representative data of
three independent experiments are shown.853 Nishikomori et al.
cell clone, D10.G4.1 (D10), with a mouse IL-12Rb2 chain
cDNA (containing a FLAG tag sequence just before the
terminal codon) under a CD2 promoter/enhancer (see
Materials and Methods). As shown in Fig. 4, A and B, the
stable transfectants thus obtained did express IL-12Rb2
chain as determined by Western blotting with an anti-
FLAG antibody and by flow cytometry using an anti–
mouse IL-12Rb2 chain–specific antibody. In addition, as
shown in Fig. 4 B, using flow cytometry we showed that
D10 cells express endogenous IL-12Rb1 chain. Thus, the
transfected cells could express a competent IL-12R. To
confirm the latter point, we stimulated transfected D10
cells with IL-12 and showed that such stimulation results in
tyrosine phosphorylation of both STAT3 and STAT4 in
transfected cells but not in mock-transfected cells; in addi-
tion, such stimulation leads to proliferation of transfected
D10 cells (data not shown). Therefore, we concluded that
the transfected D10 cells did in fact express functional IL-
12Rs and that reconstituted IL-12 signaling in differenti-
ated Th2 cell induces the T cells to proliferate.
In further studies, we determined if signaling of D10
cells via the transfected IL-12Rb2 chain could convert
these cells from Th2 cells making large amounts of IL-4 but
little or no IFN-g into Th1 cells that make large amounts
of IFN-g (34). Accordingly, we stimulated transfected and
control nontransfected or vector-transfected D10 cells with
either anti-CD3e plus anti-CD28 with or without IL-12,
IL-12 plus IL-18, or irradiated APCs plus antigen (conal-
bumin) with or without IL-12. As shown in Table III, we
detected IFN-g production at a modest level in only one
out of three transfectants (clone NE7), mainly after anti-
CD3e plus anti-CD28 stimulation. Interestingly, all of the
transfectants (including the IFN-g–producing clone) still
produced large amounts of IL-4 at a level similar to that of
the parental cells or mock-transfected cells. Thus, these
data show that IL-4 production cannot be extinguished and
a high level of IFN-g production cannot be induced in an
established Th2 clone simply by reacquisition of the IL-
12Rb2 chain and IL-12 signaling.
Effect of Persistent IL-12R Expression on Primary Th2 Cell
Lines. To investigate the convertibility of a newly estab-
lished Th2 cell line, we turned again to cells obtained from
IL-12Rb2 chain transgenic mice. In these studies, we first
established Th2 cell lines from double and single transgenic
mice expressing both the IL-12Rb2 chain transgene and an
OVA-specific TCR transgene or only an OVA-specific
TCR transgene, respectively (35). This was accomplished
by stimulation of naive CD41 T cells in the presence of
IL-4 and then culturing the Th2 cell lines obtained under
Th1 cell conditions (IL-12 [2 ng/ml] and anti–IL-4 mAb
[10 mg/ml]) for three successive antigen stimulation cycles
spaced 6 d apart. As shown in Table IV, although IFN-g
production elicited in T cell lines derived from double
transgenic mice was greater than that elicited in single
transgenic mice, the level of IFN-g was still z7–30-fold
less than obtained in double transgenic T cells primed in
the presence of IL-12. Perhaps more importantly, IL-12
signaling of the Th2 cells did not reduce the high level of
IL-4 production in double transgenic T cells, and the latter
continued to produce as much IL-4 as observed in single
transgenic T cells. In addition, as shown in Fig. 5 A, by us-
ing intracellular cytokine staining, we showed that while
IFN-g1  cells (IL-42/IFN-g1 and IL-41/IFN-g1 cells)
arose in cultures of both single and double transgenic cells
Figure 4. (A) Western blot for detection of IL-
12Rb2 chain FLAG epitopes in D10 cells trans-
fected with VAhCD2IL-12Rb2FLAG. Two broad
specific bands (130 and 150 kD) were detected in
the transfected cells with VAhCD2IL-12Rb2FLAG
(IL-12Rb2 chain) compared with mock-trans-
fected cells (mock) or parental cells (D10). After
PNGase F (New England Biolabs) treatment of ly-
sates and repeat Western blot, they gave rise to one
sharp specific band of 96 kD, the expected size
from amino acid residues of mouse IL-12Rb2
chain cDNA (data not shown). (B) IL-12Rb2
chain expression of D10 cell transfectants and en-
dogenous IL-12Rb1 chain expression of D10 cells
by flow cytometry. D10 cell transfectants were
stained with anti–mouse IL-12Rb2 chain mAb 7 d
after antigen (conalbumin) stimulation. For endog-
enous IL-12Rb1 chain expression, nontransfected
D10 cells were stained with biotinylated mouse
anti–mouse IL-12Rb1 chain mAb and streptavidin-
PE, or with biotinylated mouse anti-TNP mAb as a
negative control. Histogram of gated CD3e1 cells is
shown.854 Th2 Cell Differentiation in the Presence of IL-12Rb2 Chain Expression
(8.5 and 30.1%, respectively), IL-41/IFN-g2 cells were
still the predominant subpopulation in both single and
double transgenic cell populations (50.3 and 49.3%, respec-
tively). Interestingly, two thirds of IFN-g–producing cells
in double transgenic cells were IL-41/IFN-g1 cells. As
shown in Fig. 5 B, the Th2 cells from the double trans-
genic mice continued to exhibit IL-12 signaling indicated
by STAT4 tyrosine phosphorylation. Thus, these studies
show that even in newly differentiated Th2 cells, IL-4 pro-
duction was not terminated by IL-12Rb2 chain expression
and IL-12 signaling.
GATA-3 and c-Maf Expression in IL-12Rb2 Chain Trans-
genic Th2 Cells. GATA-3 and c-Maf are transcription fac-
tors associated with Th2 cells and have been implicated in
the termination of IL-12 signaling (11, 12, 36). Therefore,
we determined the expression of GATA-3 and c-Maf in
D10 cells and Th2 cells expressing the IL-12Rb2 chain
and then stimulated in the presence of IL-12. As shown in
Fig. 6 A, transfected D10 cells express a similar level of
GATA-3 and c-Maf in mRNA in relation to parental cells
or mock-transfected cells. In addition, as shown in Fig. 6
B, although IL-4–primed T cells from single and double
transgenic mice express both GATA-3 and c-Maf mRNA,
the addition of IL-12 in the culture did not shut down the
expression of such mRNA previously induced by IL-4.
Thus, IL-4–induced GATA-3 and c-Maf expression is not
significantly decreased by IL-12 signaling via the IL-12Rb2
chain.
Discussion
In the view of T cell differentiation, the important con-
cept has been put forward that IL-4 counterregulates Th1
cell development by controlling expression of the b2 chain
of the heterodimeric IL-12R, i.e., the receptor component
necessary for STAT4 activation and IFN-g production
(21–24). Thus, in the model of Leishmania infection occur-
ring in Balb/c mice, it has been speculated that a burst of
IL-4 production at an early stage of infection induces
downregulation of the IL-12Rb2 chain on reacting T cells,
which then leads to a dominant Th2 response and the non-
Table III. Cytokine Production of Mouse Th2 Clone D10 Cells Expressing a Transfected IL-12Rb2 Chain Gene
2 CD31CD28 CD31CD281IL-12 IL-121IL-18 Antigen Antigen1IL-12
IFN-g
D10 (parental clone) 0 0.03 0 0 0.56 0.91
VAG1 (mock transfected) 0 0 0 0 0.65 1.05
19C1 (IL-12Rb2 chain1) 0 0 0 0 0.04 0.65
ND2 (IL-12Rb2 chain1) 0 0 0 0 0 0.33
NE7 (IL-12Rb2 chain1) 0 10.57 47.32 0.46 3.02 1.69
IL-4
D10 (parental clone) 0 427 419 ND 35 32
VAG1 (mock transfected) 0 237 243 ND 32 31
19C1 (IL-12Rb2 chain1) 0 278 504 ND 22 13
ND2 (IL-12Rb2 chain1) 0 179 191 ND 4 4
NE7 (IL-12Rb2 chain1) 0 126 251 ND 41 38
The mouse Th2 clone D10 and its transfectants were stimulated as indicated; 48 h later, culture supernatants were assayed for IFN-g and IL-4
concentrations by ELISA. Results shown (in ng/ml) represent data from one of three independent experiments.
Table IV. Newly Differentiated Th2 Cells from Double 
Transgenic Mice (Expressing an IL-12Rb2 Chain Transgene) 
Maintain Th2 Phenotype after Repeated Restimulation under Th1 
Conditions
IFN-g IL-4
Antigen
CD3
1CD28
IL-12
1IL-18 Antigen
CD3
1CD28
Single Tg 1 IL-4 1 27 0 56 195
Double Tg 1 IL-4 8 194 3 125 533
Single Tg
(IL-4 ®Th1) 213 290 78 98 164
Double Tg
(IL-4 ®Th1) 634 1,524 1,101 222 214
Single Tg 1 IL-12 16,411 21,250 5,306 0 0
Double Tg 1 IL-12 20,766 24,395 7,710 0 0
CD41  cells from double transgenic mice (double Tg) and single
transgenic mice (single Tg) were primed with IL-4 (200 U/ml) for 7 d,
and restimulated with OVA peptide, APCs, IL-12 (2 ng/ml), and anti–
IL-4 mAb (10 mg/ml) every week. After three rounds of restimulation,
the CD41 T cells were stimulated as indicated. Results of control studies
in which CD41 T cells were stimulated with IL-4 four times or
stimulated with IL-12 four times are also shown. Results (in ng/ml)
shown represent data from one of three independent experiments.855 Nishikomori et al.
resolving infection characteristic of this mouse strain (37,
38). However, it should be noted that any concept that im-
plies that the IL-12Rb2 chain is a molecular switch con-
trolling Th1/Th2 cell development must contend with the
fact that the IL-12Rb2 chain is upregulated and sustained
by IL-12 or IFN-g (in the mouse) (23), so that its expres-
sion could reflect the fact that it is merely one of several
Th1 phenotypic markers rather than a controlling differen-
tiation factor. In fact, in this study we provide evidence in
support of the latter possibility in that we show that al-
though IL-12Rb2 chain downregulation may occur during
Th2 cell differentiation (defined by the ability of the CD41
T cells to produce IL-4), it is not necessary for such differ-
entiation. More particularly, we demonstrated that naive
CD41 T cells expressing a transgene for the IL-12Rb2
chain under a human CD2 promoter/enhancer and stimu-
lated in the presence of IL-12 and IL-4 develop into IL-4–
producing cells despite continued IL-12 signaling via the
IL-12R and STAT4 tyrosine phosphorylation. In addition,
we showed with Northern blotting that the Th2-specific
transcription factors GATA-3 and c-Maf induced by IL-4
are not shut down by sustained IL-12 signaling. Finally, we
demonstrated that although IFN-g production was depen-
dent on IL-12Rb2 chain expression and IL-12, IFN-g
production by CD41 T cells bearing the IL-12Rb2 trans-
gene was z10–100-fold less when primed with IL-4 and
IL-12 than when primed with IL-12 alone, even though
the level of IL-12Rb2 expression and STAT4 tyrosine
phosphorylation was the same under these two conditions.
Taken together, these findings strongly suggest that IL-4
activates a mechanism to suppress IFN-g production that is
independent of IL-12 signaling and/or suppression of the
IL-12Rb2 chain. One candidate mechanism for such IL-4–
mediated suppression is the induction of GATA-3 and/or
c-Maf, IL-4–induced transcriptional factors that have been
shown to be suppressive of IFN-g production (36, 39).
However, GATA-3 has suppressive effects on IL-12Rb2
chain expression and suppressive effects by c-Maf are over-
Figure 5. (A) Intracellular cy-
tokine staining for IL-4 and
IFN-g in IL-4–primed cell lines
from single and double trans-
genic mice restimulated three
times with OVA peptide, APCs,
and IL-12 (2 ng/ml) and anti–
IL-4 mAb (10 mg/ml). T cell
lines were harvested 7 d after
final antigen stimulation and
treated as described in the leg-
end to Fig. 3. Representative
data of three independent exper-
iments are shown. (B) Immuno-
precipitation Western blot for
detection of STAT4 tyrosine
phosphorylation in Th2 cells cultured for three cycles under Th1 conditions. IL-4–primed single and double transgenic cells were restimulated with
OVA peptide, APCs, IL-12 (2 ng/ml), and anti–IL-4 mAb (10 mg/ml) over three cycles (IL-4®Th1); 7 d after final stimulation, T cells were harvested
and restimulated with (1) or without (2) IL-12 (5 ng/ml). As controls, cells cultured with IL-4 or IL-12 for four cycles are also shown. The same blots
were stripped and reprobed with anti-STAT4 antibody.
Figure 6. (A) Northern blot studies for de-
tection of c-Maf and GATA-3 mRNA in D10
cells. D10 cells and transfectants (VAG1
[mock]; 19C1, ND2, and NE7 [IL-12Rb2
chain]) were harvested 10 d after antigen (con-
albumin) stimulation, washed extensively, and
then restimulated with surface-bound anti-
CD3e (5 mg/ml) plus soluble anti-CD28 (1
mg/ml) with (1) or without (2) IL-12 (5 ng/
ml). 6 h after restimulation, total RNA was
isolated and subjected to Northern blotting. 10
mg of total RNA was loaded in each lane. The
same blot was probed with GATA-3, c-Maf,
and GAPDH sequentially. (B) Northern blot
studies for detection of c-Maf and GATA3
mRNA in T cell lines from single and double
transgenic mice. T cell lines primed with IL-4
(200 U/ml), with IL-4 (200 U/ml) plus IL-12
(2 ng/ml), or with IL-12 (2 ng/ml) from sin-
gle and double transgenic mice were harvested
7 d after priming and restimulated with sur-
face-bound anti-CD3e (5 mg/ml) plus soluble
anti-CD28 (1 mg/ml) with (1) or without (2) IL-12 (5 ng/ml). 6 h after restimulation, total RNA was isolated and subjected to Northern blotting.
6 mg of total RNA was loaded in each lane. The same blot was probed with c-Maf, GATA-3, and GAPDH sequentially.856 Th2 Cell Differentiation in the Presence of IL-12Rb2 Chain Expression
come by the addition of IL-12; therefore, how much these
factors contribute to the direct suppressive effects of IL-4
on IFN-g production needs further analysis.
The conclusion drawn above, that Th2 differentiation
can proceed in the presence of IL-12 signaling, should not
be taken to imply that IL-12 signaling has no influence on
such differentiation. Thus, in cultures of naive single and
double transgenic T cells in the presence of IL-4 and the
absence of exogenous IL-12, the double transgenic T cells
that emerge produce more IL-4 than their single transgenic
counterparts (Table II, and Fig. 3). This can be explained
by assuming that APCs in these cultures produce some en-
dogenous IL-12, and the latter through its capacity to re-
duce the expression of the cdk inhibitor p27Kip1, via
STAT4 activation (40), results in increased T cell prolifera-
tion; in turn, this leads to greater IL-4 production because
IL-4 gene activation is highly cell cycle dependent (41).
On the other hand, double transgenic T cells cultured with
IL-4 plus exogenous IL-12 produce less IL-4 than single
transgenic T cells (Table II, and Fig. 3). This suggests that
IL-12 signaling can work against IL-4 gene activation
when cells are exposed to higher levels of IL-12. Whether
the inhibitory effect is a direct effect of IL-12 on Th2 cell
differentiation or an indirect effect of IL-12 mediated by
IFN-g (31–33) or by induction of nitric oxide synthetase 2
(42) requires further study. Finally, it should be noted that
cultures of double transgenic cells with IL-4 plus exoge-
nous IL-12 leads to the appearance of modest numbers of
IL-41/IFN-g1 cells. This may reflect the more frequent
occurrence of IL-41/IFN-g1 cells in humans than in mice
(43, 44), since in humans IFN-a can directly transduce a
STAT4 signal independently of IL-12 and the IL-12Rb2
chain and thus induce naive human CD41 T cells to be-
come IFN-g–producing cells even in the presence of IL-4
(24, 25).
In the studies reported here, we used a newly developed
mAb specific for the mouse IL-12Rb2 chain to assess ex-
pression of the latter in transgenic T cells and transfected T
cells. The data collected with the use of this antibody re-
quire some comment. First, we noted that although trans-
genic CD41 T cells cultured under a variety of conditions
express high levels of surface IL-12Rb2 chain 3 d after
stimulation, such expression declines with continued cul-
ture and is considerably reduced by 7 d (Fig. 1 B). How-
ever, it should be noted that despite this decline, IL-12 in-
duces significant proliferation (Fig. 2 A) and high levels of
STAT4 tyrosine phosphorylation (Fig. 2 B). Thus, it is ap-
parent that either STAT4 tyrosine phosphorylation is a
more sensitive index of the presence of a competent IL-
12R function than is flow cytometry with this antibody or
that even a low level of IL-12Rb2 chain expression is suffi-
cient for maximal transduction of the IL-12 signal. These
considerations make it unlikely that IL-4–induced down-
regulation of the IL-12Rb2 chain transgene and the emer-
gence of a subpopulation of cells during culture that lack
IL-12Rb2 chain expression explain the results obtained in
these studies. Further evidence in support of the latter con-
clusion is that IL-12Rb2 chain expression on cells was
manifest as a single peak on flow cytometry throughout the
period of study and that analysis of IL-12Rb2 chain ex-
pression on IL-41/IFN-g2 and IL-41/IFN-g1 cells using
intracellular cytokine staining showed that these cells re-
tained similar levels of IL-12Rb2 chain expression as IL-
42/IFN-g1 cells.
A second area addressed by these studies is the role of IL-
12Rb2 chain and IL-12 signaling on the maintenance of
Th1/Th2 phenotypes (45). Previous work in this area has
shown that repetitive stimulation of CD41 T cells via the
TCR under Th1 or Th2 cytokine conditions causes fixa-
tion of the Th1 or Th2 phenotype, respectively (26, 35,
46), and suggested that the basis of such fixation with re-
gard to Th2 cells was again the loss of IL-12Rb2 chain ex-
pression. We obtained two types of data that address the
latter hypothesis. First, we showed that an established Th2
clone (D10) stably transfected with the IL-12Rb2 chain
and capable of transducing STAT4/STAT3 tyrosine phos-
phorylation does not produce large amounts of IFN-g and
(more importantly) does not manifest decreased IL-4 pro-
duction upon stimulation in the presence of IL-12; thus,
this T cell clone does not convert to a Th1 cell. Such lack
of conversion may be due to any of several factors. One is
that IL-4 signaling negatively affects IFN-g production in-
dependently of IL-12Rb2 chain expression, as mentioned
above. Another is that differentiation of Th2 cells is accom-
panied by epigenetic changes such as methylation of the
IFN-g promoter and establishment of DNaseI hypersensi-
tivity sites in cytokine gene regions that, in effect, make
back-differentiation a nonregulatable and irreversible pro-
cess (34, 47–49). In any case, the effects of Th2 differentia-
tion are not absolute in that one clone of D10 cells express-
ing the IL-12R did make small amounts of IFN-g. Finally,
it is clear that not all IL-12 signaling pathways in D10 cells
are inoperative, as D10 cells proliferate in response to IL-12
stimulation.
Another and perhaps more cogent way in which we ex-
amined the convertibility of the Th2 cell was to examine
early Th2 cells produced by a single round of stimulation of
naive CD41 T cells from IL-12Rb2 transgenic mice with
IL-4, although IL-4–primed CD41 T cells lines contain
few IFN-g–producing cells and IL-42/IFN-g2 cells, which
means that the starting population was not a pure Th2 cell
line (26, 35). In these studies, we showed that repeated
restimulation of such cells in the presence of IL-12 and
anti–IL-4 mAb (i.e., in the presence of Th1 condition) did
not reverse their basic Th2 phenotype or IL-4 produc-
tion capability even when IL-12 signaling is maintained.
Therefore, these studies show that the irreversible commit-
ment to IL-4 production occurs early and occurs irrespec-
tive of signaling via the IL-12R. As in the case of estab-
lished D10 Th2 clones, IFN-g production of double
transgenic Th2 cell lines cultured sequentially with exoge-
nous IL-12 and anti–IL-4 mAb was only about a tenth of
that of T cell lines cultured with IL-12 (Table IV). How-
ever, it should be noted that the IL-12Rb2 chain transgene
driven by the human CD2 promoter/enhancer used in
these studies appeared to be somewhat downregulated by857 Nishikomori et al.
IL-4 (Fig. 1 B) and possibly by other factors as well. Thus,
the IFN-g production difference might be due either to
suppression of IFN-g gene expression by IL-4–related fac-
tors or to lower expression of IL-12Rb2 chain in the dou-
ble transgenic Th2 lines cultured sequentially with exoge-
nous IL-12 and anti–IL-4 mAb.
In summary, using IL-12Rb2 chain transgenic mice and
anti–mouse IL-12Rb2 mAb, we demonstrated that Th2
cell differentiation can occur in the presence of IL-12Rb2
chain and IL-12 signaling, and that once the IL-4 gene is
activated IL-4 production cannot be shut down by IL-12
signaling.
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